QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ)
$4.45 -0.22 (-4.7109%)
Analysed QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) News Sources
Quoin Pharmaceuticals to Announce Corporate Update and First Quarter 2026 Financial Results on Thursday, May 7, 2026
30-04-2026
yahoo.com
Quoin Pharmaceuticals Provides Corporate Update and Reports First Quarter 2026 Financial Results
07-05-2026
yahoo.com
QNRX: Targeting Completing Recruitment for NS Trial by YE26
12-05-2026
yahoo.com
Quoin Pharmaceuticals Submits IND Application for QRX003 in Peeling Skin Syndrome
02-06-2026
yahoo.com
Quoin Pharmaceuticals Announces Japan's MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome
04-06-2026
yahoo.com
Quoin Pharmaceuticals Announces Positive Clinical Update from Ongoing Pediatric Netherton Syndrome Compassionate Use Program
16-06-2026
yahoo.com
Quoin Pharmaceuticals Completes Establishment of Japanese Subsidiary to Advance Commercial Readiness for QRX003
18-06-2026
yahoo.com
Quoin Pharmaceuticals Receives FDA Conditional Approval of QYLEKI™ as the Proposed Brand Name for QRX003 for Netherton Syndrome
23-06-2026
yahoo.com
Quoin Pharmaceuticals Receives U.S. Notice of Allowance for Patent Covering Combination Treatment for Netherton Syndrome
30-06-2026
yahoo.com
Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome
09-07-2026
yahoo.com
What is the current price of QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ)?
The current price of QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) is $4.45.
QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) since the previous trading day is $-0.22.
QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) since the previous trading day is -4.7109%.
What is the most recent average sentiment score for QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ)?
The most recent average sentiment score for QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ)?
The most recent sentiment for QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) is .
SEC-8K** Filing Available For QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.